DEBORAH STEGNER: Open Payments
NPI 1033265715 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,544 in 84 payments from 15 companies in 2025. Trend: 2023 $1,038 · 2024 $1,714 · 2025 $1,544
Food & beverage: $1,421Education: $123
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $252 |
| Supernus Pharmaceuticals, Inc. | 12 | $235 |
| Vanda Pharmaceuticals Inc. | 6 | $171 |
| Teva Pharmaceuticals USA, Inc. | 4 | $169 |
| Lundbeck LLC | 10 | $135 |
| Otsuka America Pharmaceutical, Inc. | 4 | $105 |
| Axsome Therapeutics, Inc. | 4 | $101 |
| Alkermes, Inc. | 3 | $78 |
| Almatica Pharma LLC | 3 | $59 |
| Biogen, Inc. | 2 | $58 |
Products named: VRAYLAR, Qelbree, REXULTI, FANAPT, Auvelity, LYBALVI, LOREEV XR, ZURZUVAE.
Industry payments across AZ — which companies pay providers there.
